Acta Pharmaceutica Sinica B
|
2025, 15(10): 5491-5492
• Commentaries •
Advances in selective targeting of serine hydrolases: A targeted covalent approach against hCES2A mitigates irinotecan toxicity in vivo
Full
Elena De Vita1
Affiliations
1 Centre for Molecular Cell Biology, Department of Biochemistry, School of Biological and Behavioural Sciences, Queen Mary University of London, London E1 4NS, UK
doi: 10.1016/j.apsb.2025.09.023
Outline
Human carboxylesterase 2 (hCES2A)
/
Structure-based drug design (SBDD)
/
Donepezil derivatives
/
Structure-activity relationship (SAR)
Elena De Vita.
Advances in selective targeting of serine hydrolases: A targeted covalent approach against hCES2A mitigates irinotecan toxicity in vivo[J].
Acta Pharmaceutica Sinica B,
2025
, 15
(10)
: 5491
-5492
.
DOI: 10.1016/j.apsb.2025.09.023
Year 2025 volume 15 Issue 10
PDF
6
4
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.09.023